- $736.31m
- $1.61bn
- $9.41bn
- 79
- 77
- 69
- 88
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,129 | 4,010 | 7,417 | 9,143 | 9,413 |
Cost of Revenue | |||||
Gross Profit | 643 | 791 | 998 | 1,140 | 1,284 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,127 | 3,930 | 7,275 | 8,976 | 9,295 |
Operating Profit | 1.32 | 80.3 | 142 | 167 | 118 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -40.5 | 30.4 | 70.9 | 108 | 46.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -46.7 | 31.9 | 59.2 | 72.1 | 34.6 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -43.5 | 13.7 | 59.2 | 71.7 | 34.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -43.5 | 10.4 | 53.5 | 66 | 28.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.323 | 0.211 | 0.46 | 0.64 | 0.47 |
Dividends per Share |